97 related articles for article (PubMed ID: 28121350)
1. Thrombomodulin regulates doxorubicin sensitivity through epithelial-mesenchymal transition in non-small cell lung cancer.
Yang Y; Cheng BJ; Lu S
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):95-101. PubMed ID: 28121350
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin reduces tumorigenic and metastatic potential of lung cancer cells by up-regulation of E-cadherin and down-regulation of N-cadherin expression.
Zheng N; Huo Z; Zhang B; Meng M; Cao Z; Wang Z; Zhou Q
Biochem Biophys Res Commun; 2016 Aug; 476(4):252-259. PubMed ID: 27223053
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition.
Jin Z; Guan L; Song Y; Xiang GM; Chen SX; Gao B
Eur Rev Med Pharmacol Sci; 2016; 20(6):1080-6. PubMed ID: 27049260
[TBL] [Abstract][Full Text] [Related]
4. The Effect of TIGAR Knockdown on Apoptotic and Epithelial-Mesenchymal Markers Expression in Doxorubicin-Resistant Non-Small Cell Lung Cancer A549 Cell Lines.
Agca CA; Kırıcı M; Nedzvetsky VS; Gundogdu R; Tykhomyrov AA
Chem Biodivers; 2020 Sep; 17(9):e2000441. PubMed ID: 32639659
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
Chang YJ; Cheng YW; Lin RK; Huang CC; Chen WT; Ke TW; Wei PL
PLoS One; 2016; 11(8):e0160550. PubMed ID: 27512995
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
9. ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.
Xu T; Zhang J; Chen W; Pan S; Zhi X; Wen L; Zhou Y; Chen BW; Qiu J; Zhang Y; Yang Q; Feng X; Bai X; Liang T
Cancer Lett; 2016 Jul; 377(2):140-8. PubMed ID: 27126361
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
11. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
12. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
Xu G; Yu H; Shi X; Sun L; Zhou Q; Zheng D; Shi H; Li N; Zhang X; Shao G
BMC Pulm Med; 2014 Nov; 14():174. PubMed ID: 25380840
[TBL] [Abstract][Full Text] [Related]
15. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition contributes to docetaxel resistance in human non-small cell lung cancer.
Shen W; Pang H; Liu J; Zhou J; Zhang F; Liu L; Ma N; Zhang N; Zhang H; Liu L
Oncol Res; 2014; 22(1):47-55. PubMed ID: 25700358
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma.
Pan JX; Wang F; Ye LY
Biochem Biophys Res Commun; 2016 Oct; 479(4):610-614. PubMed ID: 27697528
[TBL] [Abstract][Full Text] [Related]
18. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.
Rastogi I; Rajanna S; Webb A; Chhabra G; Foster B; Webb B; Puri N
Biochem Biophys Res Commun; 2016 Sep; 477(4):937-944. PubMed ID: 27396618
[TBL] [Abstract][Full Text] [Related]
20. Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.
Ren S; Su C; Wang Z; Li J; Fan L; Li B; Li X; Zhao C; Wu C; Hou L; He Y; Gao G; Chen X; Ren J; Li A; Xu G; Zhou X; Zhou C; Schmid-Bindert G
Int J Cancer; 2014 Dec; 135(12):2962-71. PubMed ID: 24771540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
